Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae-Cheol Lee

Showing results (81-90 of 226) with videos related to

Pageof 23
Sort By:
Plos One|January 10, 2019
Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practiceDong Kyu Oh, Won Jun Ji, Woo Sung Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|July 7, 2009
Age at diagnosis predicts outcomes in gefitinib-treated female patients with non-small-cell lung cancerIm Il Na, Du Hwan Choe, Cheol Hyeon Kim, et al.
Journal of Cancer Research and Clinical Oncology|June 26, 2020
Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive diseaseSoo Han Kim, Chang-Min Choi, Dae Ho Lee, et al.
Thoracic Cancer|August 8, 2019
Effect of medical thoracoscopy-guided intrapleural docetaxel therapy to manage malignant pleural effusion in patients with non-small cell lung cancer: A pilot studyMyeong Geun Choi, Sojung Park, Dong Kyu Oh, et al.
Cancer Research and Treatment|December 5, 2022
Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor TreatmentYoon Jung Jang, Dong-Gon Hyun, Wonjun Ji, et al.
Cancer Research|February 7, 2007
p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancerJin Kyung Rho, Yun Jung Choi, Baek-Yeol Ryoo, et al.
Plos One|April 17, 2020
Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasisDong-Gon Hyun, Chang-Min Choi, Dae Ho Lee, et al.
Translational Lung Cancer Research|July 23, 2021
Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective studyMyeong Geun Choi, Chang-Min Choi, Dae Ho Lee, et al.
Journal of Clinical Medicine|January 16, 2020
Clinical Characteristics of and Risk Factors for Fever after Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A Retrospective Study Involving 6336 PatientsKyoung Min Moon, Chang-Min Choi, Wonjun Ji, et al.
Oncology Reports|December 14, 2018
[Corrigendum] AXL and MET receptor tyrosine kinases are essential for lung cancer metastasisYun Jung Choi, Ji Hye Kim, Jin Kyung Rho, et al.
Pageof 23

Showing results (81-90 of 226) with videos related to

Sort By:
Pageof 23
Plos One|January 10, 2019
Efficacy, safety, and resistance profile of osimertinib in T790M mutation-positive non-small cell lung cancer in real-world practiceDong Kyu Oh, Won Jun Ji, Woo Sung Kim, et al.
Lung Cancer (Amsterdam, Netherlands)|July 7, 2009
Age at diagnosis predicts outcomes in gefitinib-treated female patients with non-small-cell lung cancerIm Il Na, Du Hwan Choe, Cheol Hyeon Kim, et al.
Journal of Cancer Research and Clinical Oncology|June 26, 2020
Clinical outcomes of nivolumab in patients with advanced non-small cell lung cancer in real-world practice, with an emphasis on hyper-progressive diseaseSoo Han Kim, Chang-Min Choi, Dae Ho Lee, et al.
Thoracic Cancer|August 8, 2019
Effect of medical thoracoscopy-guided intrapleural docetaxel therapy to manage malignant pleural effusion in patients with non-small cell lung cancer: A pilot studyMyeong Geun Choi, Sojung Park, Dong Kyu Oh, et al.
Cancer Research and Treatment|December 5, 2022
Optimal Definition of Oligometastasis Showing Survival Benefits of Local Therapies during Tyrosine Kinase Inhibitor TreatmentYoon Jung Jang, Dong-Gon Hyun, Wonjun Ji, et al.
Cancer Research|February 7, 2007
p53 enhances gefitinib-induced growth inhibition and apoptosis by regulation of Fas in non-small cell lung cancerJin Kyung Rho, Yun Jung Choi, Baek-Yeol Ryoo, et al.
Plos One|April 17, 2020
Outcomes according to initial and subsequent therapies following intracranial progression in patients with EGFR-mutant lung cancer and brain metastasisDong-Gon Hyun, Chang-Min Choi, Dae Ho Lee, et al.
Translational Lung Cancer Research|July 23, 2021
Different prognostic implications of hepatic metastasis according to front-line treatment in non-small cell lung cancer: a real-world retrospective studyMyeong Geun Choi, Chang-Min Choi, Dae Ho Lee, et al.
Journal of Clinical Medicine|January 16, 2020
Clinical Characteristics of and Risk Factors for Fever after Endobronchial Ultrasound-Guided Transbronchial Needle Aspiration: A Retrospective Study Involving 6336 PatientsKyoung Min Moon, Chang-Min Choi, Wonjun Ji, et al.
Oncology Reports|December 14, 2018
[Corrigendum] AXL and MET receptor tyrosine kinases are essential for lung cancer metastasisYun Jung Choi, Ji Hye Kim, Jin Kyung Rho, et al.
Pageof 23